Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease

NCT06314698 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

478

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Bone Diseases

Interventions

DRUG: Narlumosbart
DRUG: Denosumab

Sponsor

RenJi Hospital

Collaborators

[object Object]